Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 4.4B | 3.8B | 3.3B |
Cost of revenue | 4.4B | 2.5B | 2.0B | 1.6B |
Gross profit | 1.1B | 1.9B | 1.8B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 116M | 142M | 99M | 99M |
Other operating expenses | 11M | 8M | 6M | 13M |
Operating income | 961M | 1.7B | 1.6B | 1.6B |
Non operating interest income | ||||
Income | 37M | 40M | 41M | 47M |
Expense | 229M | 240M | 247M | 257M |
Other income expense | 20M | 6M | -3M | -6M |
Pretax income | 789M | 1.5B | 1.4B | 1.4B |
Tax provision | 121M | 261M | 231M | 210M |
Net income | 668M | 1.3B | 1.2B | 1.2B |
Basic EPS | 1.6 | 4.4 | 4.0 | 3.9 |
Diluted EPS | 1.6 | 4.3 | 3.9 | 3.8 |
Basic average shares | 223.5M | 224.5M | 226.3M | 228.4M |
Diluted average shares | 224.1M | 225.4M | 227M | 228.9M |
EBITDA | 1.3B | 2.1B | 2.0B | 1.9B |
Net income from continuing op. | 668M | 1.3B | 1.2B | 1.2B |
Minority interests | -315M | -307M | -314M | -282M |
Preferred stock dividends | — | — | — | — |